GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoSec Medical Inc (FRA:ONMA) » Definitions » Total Assets

OncoSec Medical (FRA:ONMA) Total Assets : €8.23 Mil (As of Jan. 2023)


View and export this data going back to 2015. Start your Free Trial

What is OncoSec Medical Total Assets?

OncoSec Medical's Total Assets for the quarter that ended in Jan. 2023 was €8.23 Mil.

Total Assets is connected with ROA %. OncoSec Medical's annualized ROA % for the quarter that ended in Jan. 2023 was -222.54%. Total Assets is also linked to Revenue through Asset Turnover. OncoSec Medical's Asset Turnover for the quarter that ended in Jan. 2023 was 0.00.


OncoSec Medical Total Assets Historical Data

The historical data trend for OncoSec Medical's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoSec Medical Total Assets Chart

OncoSec Medical Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.89 26.66 26.02 47.61 21.51

OncoSec Medical Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.02 25.92 21.51 14.66 8.23

OncoSec Medical Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

OncoSec Medical's Total Assets for the fiscal year that ended in Jul. 2022 is calculated as

Total Assets=Total Equity (A: Jul. 2022 )+Total Liabilities (A: Jul. 2022 )
=6.014+15.492
=21.51

OncoSec Medical's Total Assets for the quarter that ended in Jan. 2023 is calculated as

Total Assets=Total Equity (Q: Jan. 2023 )+Total Liabilities (Q: Jan. 2023 )
=-5.091+13.324
=8.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OncoSec Medical  (FRA:ONMA) Total Assets Explanation

Total Assets is connected with ROA %.

OncoSec Medical's annualized ROA % for the quarter that ended in Jan. 2023 is

ROA %=Net Income (Q: Jan. 2023 )/( (Total Assets (Q: Oct. 2022 )+Total Assets (Q: Jan. 2023 ))/ count )
=-25.468/( (14.656+8.232)/ 2 )
=-25.468/11.444
=-222.54 %

Note: The Net Income data used here is four times the quarterly (Jan. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

OncoSec Medical's Asset Turnover for the quarter that ended in Jan. 2023 is

Asset Turnover
=Revenue (Q: Jan. 2023 )/( (Total Assets (Q: Oct. 2022 )+Total Assets (Q: Jan. 2023 ))/ count )
=0/( (14.656+8.232)/ 2 )
=0/11.444
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

OncoSec Medical Total Assets Related Terms

Thank you for viewing the detailed overview of OncoSec Medical's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


OncoSec Medical (FRA:ONMA) Business Description

Traded in Other Exchanges
Address
24 North Main Street, Pennington, NJ, USA, 08534
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.

OncoSec Medical (FRA:ONMA) Headlines

No Headlines